$78.01 Nov 18, 2026 · market cap $14.9B
BridgeBio Pharma trades at $78. We don't have a valuation for it yet.
11 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app